Belcher: A 3D tracking system, whole animal, as small as 10 um. Looking at other types of cancer - M13 'small {lnho} phage probes' #AACR17
10:58am April 2nd 2017 via Hootsuite
Belcher: Now detect optically luminescent probes using hyperspectral and diffuse imaging (DOLPHIN) #AACR17
10:57am April 2nd 2017 via Hootsuite
Belcher: Now going back to further refine. Working on non-invasive removal of <0.2mm tumors, not enough data yet #AACR17
10:56am April 2nd 2017 via Hootsuite
Belcher: 10d post-surgery, clear difference. 3w others were missed, mouse dies at 5w. TP 98%; TN 71%. 40% OS improvement #AACR17
10:55am April 2nd 2017 via Hootsuite
Belcher: Showed video of real-time imaging, software can help analyze / segment tumors as small as 0.2mm Animal survival studies #AACR17
10:54am April 2nd 2017 via Hootsuite
Belcher: Thus tumors <1mm in size could be located and removed. Now to real-time imaging. #AACR17
10:53am April 2nd 2017 via Hootsuite
Belcher: Showed pre-surgical planning imaging, then post-unguided. Then goes in again, can remove more. (animal model) #AACR17
10:52am April 2nd 2017 via Hootsuite
Belcher: Unmet need - surgery debulking is done by eye. Gold std is contrast-enhanced CT. '14 PNAS https://t.co/2f5IE7buTW #AACR17
10:51am April 2nd 2017 via Hootsuite
Belcher: #AACR17 (For those watching at home - NSF video 'using viruses to make batteries' https://t.co/owHoFsWZhe )
10:49am April 2nd 2017 via Hootsuite
Belcher: OvCa majority dev drug resistance, OS has had little progress in past 30y. #AACR17
10:48am April 2nd 2017 via Hootsuite
Belcher: Less expensive than MRI, not CT (no radioactivity), using NIR optical detection. Ov Ca - 250K, 75% advanced stg #AACR17
Belcher: Took advantage of flourescence, 2nd-window NIR. Rolled up along w/the nanotube. Thus - when bound, M13 will light up tube #AACR17
10:47am April 2nd 2017 via Hootsuite
MT @gg_schwind: @kochinstitute @MIT Dr. Angela Belcher demonstrating that #cancer is like rocket science ... #AACR17 https://t.co/BzHJ7WQhlz
10:46am April 2nd 2017 via Hootsuite
RT @AEDeconinck: Engineer speaking in Opening Plenary #AACR17. Is this a first?? https://t.co/bzBxbOn7Y9
Belcher: Virus-powered cars, 'from energy to cancer'. Showed MnO4, Pd binding properties video #AACR17
10:45am April 2nd 2017 via Hootsuite
Belcher: Took a combinatorial approach, 1B comb's, did selection for peptide libraries. Huge list of Nature, Nature Materials pubs #AACR17
10:44am April 2nd 2017 via Hootsuite
Belcher: Shows a model of graphene sheet, rolled into a nanotube. M13 to pick up nanotubes. And wired to current collectors. #AACR17
10:43am April 2nd 2017 via Hootsuite
Belcher: Uses a model of M13 bacteriophage. (With LEDs!) engineering M13 for solar cells and batteries. #AACR17
Belcher: Working on imaging and therapeutics; 'give biology the oppy to work with the entire periodic table' #AACR17
10:42am April 2nd 2017 via Hootsuite
Belcher: Has as large a disclosure slide as George Church (but on materials side). Shows abalone shell - 50M years to get there #AACR17
10:41am April 2nd 2017 via Hootsuite
Belcher: A similar problem - brings up a 3D printed of a 3cm tumor, Stg III-IV. Now - 0.5cm finding - reduce 50% ov ca mortality #AACR17
10:39am April 2nd 2017 via Hootsuite
Belcher: "It's not rocket science - or is it?" 170M particles in space that we're tracking, 1cm in size (!!) #AACR17
10:38am April 2nd 2017 via Hootsuite
Belcher: Because this (cancer research) 'is the most important problem'. A material science perspective. #AACR17
Belcher: Has worked prior in solar cells and catalysts; now at the Koch Inst, wroking on cancer. "I was very intimidated" #AACR17
10:37am April 2nd 2017 via Hootsuite
Belcher: Has studied nanomaterials; 100K's of atoms, controlling where atoms are placed, changing their properties. #AACR17
10:36am April 2nd 2017 via Hootsuite
Angela Belcher (MIT MA) New approaches for finding tiny tumors: towards early detection and trtmnt of ovariant cancer #AACR17
Davidson: #AACR17 The magnitude of the proposed cuts 'are truly appalling'. Would severely hamper efforts in the future.
10:26am April 2nd 2017 via Hootsuite
#AACR17 No other organization has the scope, expertise, and drive to meet (the challenge of changing the face of cancer).
10:23am April 2nd 2017 via Hootsuite
Caligiuri #AACR17 Project Genie - https://t.co/hqnoSo6j0g will impact treatment, prevention, pt involvement.
10:21am April 2nd 2017 via Hootsuite
Calligiuri #AACR17 - Big data will transform our understanding of cancer, just like it has transformed our experience of buying a book.
Video at #AACR17 now with several survivor stories; one TNBC right before the holidays (and her 39th birthday).
10:19am April 2nd 2017 via Hootsuite
Davidson: #AACR17 Have high-school and post-graduate programs; encouraging engagement with senior researchers.
Davidson: #AACR17 All outstanding opportunities to take these therapies from the bench to the bedside - and back again.
10:18am April 2nd 2017 via Hootsuite
TIL here at #AACR17 the @AACR organization has over 220 staff. Nancy Davidson: 'we now have several well-defined screening technologies'
10:17am April 2nd 2017 via Hootsuite
RT @AlexandraSurcel: Advice from Mina Bissell @AACR #AACR17 #MentoringAdvice https://t.co/VoZ0QHiWup
10:15am April 2nd 2017 via Hootsuite
Nancy Davidson (current president AACR) #AACR17 Announces publishing book 'Landmarks in Cancer 1907-2017' - video shown.
10:14am April 2nd 2017 via Hootsuite
Kimmel: #AACR17 Seems an upside-down world, where funds are being cut. 20y ago he led the march for increasing funding.
10:08am April 2nd 2017 via Hootsuite
Kimmel: #AACR17 In the fashion industry, acted in the best interests of others, took risk. After 20y of progress - but disppt'd w/present
10:06am April 2nd 2017 via Hootsuite
RT @gocheval: "You have only one life, do something good with it" Mina Bissell's signature advice #AACR17 https://t.co/1DrOBg96rw
10:04am April 2nd 2017 via Hootsuite
#AACR17 Distinguished Public Service award - Sidney Kimmel, philantropist. $25M for Stand Up to Cancer @SU2C to $150M to Hopkins
10:03am April 2nd 2017 via Hootsuite
Reese: #AACR17 "Our missions are closely aligned."
10:00am April 2nd 2017 via Hootsuite
Dr. David Reese at #AACR17 from Amgen - announcement of $1M unrestricted funds for AACR to advance research.
9:55am April 2nd 2017 via Hootsuite
Croce: #AACR17 Coding genome at <2%; rest is not 'junk' - non-coding can be involved w/oncogenesis.
9:51am April 2nd 2017 via Hootsuite
RT @Rick__Buck: Thank you @JackWhelan for your great advocacy for cancer research & @AACR. Congrats on your service award #AACR17 https:
9:51am April 2nd 2017 via Twitter Web Client
Croce: #AACR17 First gene to affect epigenetic status as an oncogene. In CLL, mIR-15a and several others lost in CLL - non-coding genome
9:49am April 2nd 2017 via Hootsuite
Croce: #AACR17 With a talented post-doc, cloned bcr/abl. Then characterized ALL1 (now called CML1), also partial duplication
9:48am April 2nd 2017 via Hootsuite
Croce: #AACR17 Disregulation of MYC oncogene by chromosomal translocation in Burkitt's lymphoma; the underlying principle for targeted Rx
9:47am April 2nd 2017 via Hootsuite
Foti award at #AACR17 for Leadership and Extraordinary achievements - Carlo Croce of The Ohio State Univ
9:46am April 2nd 2017 via Hootsuite
Whelan: #AACR17 Now back onto clin trials for PrCa; very exciting time, the word 'hope' is used with new diagnostic tests.
9:41am April 2nd 2017 via Hootsuite
Whelan: #AACR17 Without DRE and PSA, backed away from over-diagnosis. 'We need to engage the whole diagnostic field'. Chose std of care
9:40am April 2nd 2017 via Hootsuite
